SCHEMBL30396178

SCHEMBL30396178

Fc1c(Br)ccc2ncncc12

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 15/20 0.44
▸ RPS6KA5 O75582 1/20 0.32
▸ AXL P30530 1/20 0.32
▸ MAP4K4 O95819 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30047586 0.80 EGFR (0.38) EGFRMAP4K4
SCHEMBL30003592 0.77 EGFR (0.36) EGFRRPS6KA5AXL
SCHEMBL1502533 0.72 EGFR (0.47) EGFRAXL
SCHEMBL2179047 0.71 MAPT (0.58) EGFRAXL
SCHEMBL1320618 0.70 HTT (0.38) RPS6KA5
SCHEMBL31460929 0.70 GRM4 (0.38) —
SCHEMBL1571411 0.70 ESR1 (0.35) —
SCHEMBL26679791 0.70 GRM4 (0.38) —
SCHEMBL17531168 0.69 EGFR (0.36) EGFRMAP4K4
SCHEMBL27779914 0.69 ESR1 (0.40) EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116096710-A 4-oxo-3, 4-dihydroquinazolinone compounds for the treatment of BRAF related diseases and disorders 阿雷生物药品公司 2023-05-09 — — CN disclosed
Send feedback